Company: CGC
Filing Date: 2025-05-30
Form Type: POS AM
Source: 0001104659-25-054925
Chunk: 78

Company: Canopy Growth Corp
Filing Date: 2025-05-30
Form: POS AM
Chunk 78
---
 17, 2022 pursuant to an Option Agreement, dated as of May 17, 2022, by and among Canopy Oak and the other parties thereto (the “Secondary Option Agreement”); and (c) on November 4, 2022 and March 17, 2023 pursuant to the Third Amendment to Tax Receivable Agreement (the “TRA Amendment”), dated as of October 24, 2022, by and among us, Canopy USA, LLC, a Delaware limited liability company (“Canopy USA”), Acreage Holdings America, Inc., a Nevada Corporation, High Street Capital Partners, LLC, a Delaware limited liability company (“HSCP”), and certain members of HSCP.

2.

up to 2,292,946 Shares (the “September 2023 Warrant Shares”) issuable upon the exercise of warrants (the “September 2023 Warrants”) issued in connection with a private placement of units on September 19, 2023 (the “September 2023 Private Placement”). Each unit (the “September 2023 Units”) consisted of one of our common shares (“Common Shares”) and one September 2023 Warrant. Each September 2023 Warrant is exercisable for one Common Share at an exercise price of US$13.50 per share, and is exercisable for a period that commenced on September 19, 2023 and will end on September 19, 2028.

3.

up to 6,878,850 Shares (the “January 2024 Warrant Shares”) issuable upon exercise of warrants issued in connection with a private placement of units (the “January 2024 Units”) on January 19, 2024 (the “January 2024 Private Placement”), consisting of: (a) 629,940 Common Shares underlying our Series A Common Share purchase warrants (the “Series A Warrants”) and (b) 6,248,910 Common Shares underlying our Series B Common Share purchase warrants (the “Series B Warrants” and, together with the Series A Warrants, the “January 2024 Warrants”). Each January 2024 Unit consisted of (a) one Common Share and (b)(i) one Series A Warrant or (ii) one Series B Warrant. Each of the January 2024 Warrants is exercisable for one Common Share at an exercise price of US$4.83 per share. The Series A Warrants and the Series B W